Cargando…

Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020

This cross-sectional study of a sample of healthy adults assesses the seroprevalence of SARS-CoV-2 antibodies in the US asymptomatic population as of September 30, 2020.

Detalles Bibliográficos
Autores principales:	Stout, Robert L., Rigatti, Steven J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967079/ https://www.ncbi.nlm.nih.gov/pubmed/33724387 http://dx.doi.org/10.1001/jamanetworkopen.2021.1552

Ejemplares similares

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
por: Bajema, Kristina L., et al.
Publicado: (2020)

Population-Based Estimates of SARS-CoV-2 Seroprevalence in Houston, TX as of September 2020
por: Symanski, Elaine, et al.
Publicado: (2021)

SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey
por: Murhekar, Manoj V, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
por: Shakiba, Maryam, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands
por: Petersen, Maria Skaalum, et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2 antibodies in radio and television workers
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel
por: Leister, Iris, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in low-income university students
por: Araújo, Adriano Antunes de Souza, et al.
Publicado: (2021)

Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years — Mississippi, May–September 2020
por: Hobbs, Charlotte V., et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in schoolchildren in the city of São Paulo, 2020
por: Kamioka, Gabriela Akemi, et al.
Publicado: (2023)

Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022
por: Clarke, Kristie E.N., et al.
Publicado: (2022)

Trends in Decarceration, COVID-19 Cases, and SARS-CoV-2 Testing in US Immigration Detention Centers From September 2020 to August 2021
por: Uppal, Nishant, et al.
Publicado: (2022)

Seroprevalence of anti-SARS-CoV2 Antibodies in Umbrian Persons Living with HIV
por: Papalini, Chiara, et al.
Publicado: (2020)

SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort
por: Eisenhut, Katharina, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in 2115 blood donors from Romania
por: Olariu, Tudor Rares, et al.
Publicado: (2021)

Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy
por: Ferrari, Martina, et al.
Publicado: (2023)

Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection
por: Choe, Pyoeng Gyun, et al.
Publicado: (2021)

Asymptomatic SARS-CoV-2 Infection in Nursing Homes, Barcelona, Spain, April 2020
por: Borras-Bermejo, Blanca, et al.
Publicado: (2020)

Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022
por: Falender, Rebecca A., et al.
Publicado: (2023)

Screening Programs for SARS-CoV-2 Infections on a University Campus — Austin, Texas, September 30–November 30, 2020
por: Nerhood, Kayleigh J., et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in Seattle, Washington: October 2019–April 2020
por: McCulloch, Denise J., et al.
Publicado: (2021)

Seroprevalence of Antibodies to SARS-CoV-2 in Rural Households in Eastern Uganda, 2020-2022
por: Briggs, Jessica, et al.
Publicado: (2023)

SARS-CoV-2 has been circulating in northeastern Brazil since February 2020: evidence for antibody detection in asymptomatic patients
por: Gurgel, Ricardo Queiroz, et al.
Publicado: (2021)

SARS CoV-2 seroprevalence in a US school district during COVID-19
por: Bullis, Sean S M, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
por: Borges, Lysandro Pinto, et al.
Publicado: (2020)

The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia
por: Mahallawi, Waleed H., et al.
Publicado: (2021)

Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients
por: Choe, Pyoeng Gyun, et al.
Publicado: (2020)

U.S. CDC support to international SARS-CoV-2 seroprevalence surveys, May 2020–February 2022
por: Ben Hamida, Amen, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020
por: Capai, Lisandru, et al.
Publicado: (2020)

Seroprevalence of Antibodies to SARS-CoV-2 in Guangdong Province, China between March to June 2020
por: Xiao, Cheng, et al.
Publicado: (2021)

Seroprevalence of anti-SARS-CoV-2 antibodies in Colombia, 2020: A population-based study
por: Mercado-Reyes, Marcela, et al.
Publicado: (2022)

The seroprevalence of SARS‐CoV‐2‐specific antibodies in children, Australia, November 2020 – March 2021
por: Koirala, Archana, et al.
Publicado: (2022)

Potential drawbacks of SARS-CoV-2 seroprevalence surveys
por: Lippi, G.
Publicado: (2021)

SARS-CoV-2 seroprevalence in the Vatican City State
por: Ralli, Massimo, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
por: Feehan, Amy K., et al.
Publicado: (2020)

Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare personnel in the Midwestern United States, September 2020–April 2021
por: Bosserman, Rachel E., et al.
Publicado: (2023)

Seroprevalence of IgM and IgG Antibodies against SARS-CoV-2 in Asymptomatic People in Wuhan: Data from a General Hospital Near South China Seafood Wholesale Market during March to April in 2020
por: LING, Rui Jie, et al.
Publicado: (2021)

Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea: a cross-sectional study
por: Nah, Eun-Hee, et al.
Publicado: (2021)

Association of the Delta SARS-CoV-2 variant with 28-day hospital mortality between December 2020 and September 2021
por: Ciuffreda, Laura, et al.
Publicado: (2022)

Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2
por: Dong, Qunfeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ar2734tie80dhdcglfegj97pqr